Company Filing History:
Years Active: 2016
Title: Christine Besselievre: Innovator in Optical Enantiomers
Introduction
Christine Besselievre is a notable inventor based in Bures sur Yvette, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of optical enantiomers. Her work has led to advancements that are crucial for the preparation of specific crystalline forms of modafinil.
Latest Patents
Christine holds a patent for a process related to the preparation of crystalline forms of optical enantiomers of modafinil. This invention pertains to a polymorphic form of (−)-modafinil, which produces a powder X-ray diffraction spectrum with intensity peaks corresponding to interplanar spacings of about 8.54, 4.56, and 3.78 Å. This patent highlights her innovative approach to enhancing the properties of pharmaceutical compounds.
Career Highlights
Throughout her career, Christine has worked with prominent companies in the pharmaceutical industry, including Teva Santé. Her expertise in the field has allowed her to contribute to various projects that focus on drug development and optimization.
Collaborations
Christine has collaborated with notable professionals in her field, including Olivier Neckebrock and Laurent Courvoisier. These partnerships have further enriched her work and expanded the impact of her inventions.
Conclusion
Christine Besselievre is a pioneering inventor whose work in optical enantiomers has made a significant impact in the pharmaceutical industry. Her innovative contributions continue to influence the development of effective medications.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.